IVERIC bio Inc (ISEE) Forecast, Price Target & Analyst Ratings

NASDAQ:ISEE • US46583P1021

Current stock price

39.95 USD
+0.15 (+0.38%)
At close:
39.94 USD
-0.01 (-0.03%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IVERIC bio Inc (ISEE).

Forecast Snapshot

Consensus Price Target

Price Target
$39.88
-0.17% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 24, 2023
Period
Q2 / 2023
EPS Estimate
-$0.52
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
52.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$39.88
Upside
-0.17%
From current price of $39.95 to mean target of $39.88, Based on 14 analyst forecasts
Low
$31.31
Median
$40.80
High
$42.00

Price Target Revisions

1 Month
-0.38%
3 Months
25.45%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for ISEE. The average price target is 39.88 USD. This implies a price decrease of -0.17% is expected in the next year compared to the current price of 39.95.
The average price target has been revised upward by 25.45% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ISEE Current Analyst RatingISEE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

ISEE Historical Analyst RatingsISEE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
52.86%
ISEE was analyzed by 14 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about ISEE.
In the previous month the buy percentage consensus was at a similar level.
ISEE was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-05-08TD CowenDowngrade Outperform -> Market Perform
2023-05-04BairdDowngrade Outperform -> Neutral
2023-05-03UBSDowngrade Buy -> Neutral
2023-05-02HC Wainwright & Co.Downgrade Buy -> Neutral
2023-05-01GuggenheimDowngrade Buy -> Neutral
2023-05-01WedbushDowngrade Outperform -> Neutral
2023-04-25Morgan StanleyMaintains Overweight
2023-04-03WedbushReiterate Outperform
2023-03-02HC Wainwright & Co.Reiterate Buy
2023-02-21B. Riley SecuritiesMaintains Neutral
2023-02-17HC Wainwright & Co.Reiterate Buy
2022-11-10JefferiesDowngrade Buy -> Hold
2022-11-04HC Wainwright & Co.Maintains Buy
2022-09-08StifelMaintains Buy
2022-09-07GuggenheimMaintains Buy
2022-09-07BairdMaintains Outperform
2022-09-06B. Riley SecuritiesDowngrade Neutral -> Sell
2022-08-02UBSInitiate Buy
2022-07-07Morgan StanleyMaintains Overweight
2022-06-08GuggenheimInitiate Buy
2022-06-08B of A SecuritiesInitiate Buy
2022-05-12B. Riley SecuritiesInitiate Neutral
2022-03-03BairdInitiate Outperform
2022-02-07Morgan StanleyInitiate Overweight
2021-11-10HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 24, 2023
Period
Q2 / 2023
EPS Estimate
-$0.52
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-25.63%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-3.77%
EPS (3 Months)
-2.87%

Next Earnings Summary

ISEE is expected to report earnings on 7/24/2023. The consensus EPS estimate for the next earnings is -0.52 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ISEE revenue by date.ISEE revenue by date.
51.5M50.9M
-1.17%		210M
312.57%
-100.00%		10.253M115.56M
1,027.08%		345.93M
199.35%		615.92M
78.05%		998.72M
62.15%		1.381B
38.28%		1.725B
24.91%		1.984B
15.01%
EBITDA
YoY % growth
ISEE ebitda by date.ISEE ebitda by date.
-122.8M-194.8M
-58.63%		110.8M
156.88%		-60.18M
-158.75%		N/A
6.14%		-91.347M
-45.01%		-109.926M
-29.48%		-176.886M
-65.42%		-236.497M
-24.62%		-174.783M
26.09%		48.347M
127.66%		214.84M
344.37%		583.76M
171.72%		1.238B
112.07%		1.902B
53.63%		2.471B
29.92%
EBIT
YoY % growth
ISEE ebit by date.ISEE ebit by date.
-123.5M-195.6M
-58.38%		108M
155.21%		-60.18M
-160.46%		-60.531M
6.13%		-80.435M
-44.70%		-112.935M
-29.38%		-176.574M
-65.49%		-247.949M
-30.56%		-184.704M
25.51%		-12.073M
93.46%		228.93M
1,996.29%		522.66M
128.31%		835.31M
59.82%		1.105B
32.29%		1.303B
17.92%
Operating Margin
ISEE operating margin by date.ISEE operating margin by date.
-239.81%-384.28%51.43%N/AN/AN/AN/AN/A-2,418.31%-159.83%-3.49%37.17%52.33%60.49%64.06%65.68%
EPS
YoY % growth
ISEE eps by date.ISEE eps by date.
-3.02-5.45
-80.46%		3.17
158.17%		-1.59
-152.68%		-1.36
18.46%		-1.01
16.28%		-1.11
0.88%		-1.46
-34.51%		-1.84
-21.05%		-1.32
28.10%		-0.03
97.43%		1.32
3,980.29%		3.49
164.83%		4.27
22.19%		5.09
19.24%		5.72
12.42%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.52
-25.63%		-0.50
-44.26%		-0.46
1.26%		-0.41
23.02%		-0.37
27.72%		-0.28
44.44%		-0.24
47.25%
Revenue
Q2Q % growth		3.233M8.702M10.29M20.15M33.052M
922.33%		48.253M
454.50%
EBITDA
Q2Q % growth		-76.817M
-54.54%		-75.803M
-78.65%		-71.267M
-13.42%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-69.803M
-40.30%		-69.446M
-63.36%		-66.144M
-5.04%		-48.246M
34.66%		-37.23M
46.66%		-21.93M
68.42%		-9.996M
84.89%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ISEE Yearly Revenue VS EstimatesISEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
ISEE Yearly EPS VS EstimatesISEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.52%
EPS Next 5 Year
33.86%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
31.50%
EBIT Next 5 Year
39.62%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IVERIC bio Inc / ISEE Forecast FAQ

What is the average price target for IVERIC bio Inc (ISEE) stock?

14 analysts have analysed ISEE and the average price target is 39.88 USD. This implies a price decrease of -0.17% is expected in the next year compared to the current price of 39.95.

Can you provide the upcoming earnings date for IVERIC bio Inc?

IVERIC bio Inc (ISEE) will report earnings on 2023-07-24, before the market open.

What are the consensus estimates for IVERIC bio Inc (ISEE) next earnings?

The consensus EPS estimate for the next earnings of IVERIC bio Inc (ISEE) is -0.52 USD and the consensus revenue estimate is 0 USD.

How many analysts cover IVERIC bio Inc (ISEE) stock?

The number of analysts covering IVERIC bio Inc (ISEE) is 14.